1-[3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-5-phenyl-3,4-dihydropyrazol-2-yl]propan-1-one | 1252882-34-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-[3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-5-phenyl-3,4-dihydropyrazol-2-yl]propan-1-one
• CAS: 1252882-34-0
• 化学式: C₂₂H₂₁ClN₄O
• 分子量: 392.888
• InChiKey: YCRMROVRQGPPDR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  50.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  丙酸 、 3-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one 在 一水合肼 作用下， 反应 12.0h， 以87.1%的产率得到1-[3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-5-phenyl-3,4-dihydropyrazol-2-yl]propan-1-one
  参考文献：
  名称：

  Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline

  摘要：

  A series of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazolines were synthesized in one step by condensing suitably substituted propenones, hydrazine and acenc/propionic acid. The newly synthesized pyrazolines were characterized by analytical and spectral data. The new compounds were screened for analgesic and anti-inflammatory activity and most of them showed good activity comparable with that of standard drugs Pentazocin and Diclofinac sodium respectively. (C) 2010 Elsevier Masson SAS All rights reserved.

  DOI：

  10.1016/j.ejmech.2010.07.032

文献信息

• Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline
  作者：K.S. Girisha、Balakrishna Kalluraya、Vijaya Narayana、Padmashree

  DOI：10.1016/j.ejmech.2010.07.032

  日期：2010.10

  A series of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazolines were synthesized in one step by condensing suitably substituted propenones, hydrazine and acenc/propionic acid. The newly synthesized pyrazolines were characterized by analytical and spectral data. The new compounds were screened for analgesic and anti-inflammatory activity and most of them showed good activity comparable with that of standard drugs Pentazocin and Diclofinac sodium respectively. (C) 2010 Elsevier Masson SAS All rights reserved.